Controlled Decompression Attenuates Compressive Injury Following Traumatic Brain Injury Via TREK-1-Mediated Inhibition of Necroptosis and Neuroinflammation

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2021 Nov 18

PMID 34790287

Citations 6

Authors

Tao Chen

Xiao Qian

Jie Zhu

Li-Kun Yang

Yu-Hai Wang

Affiliations

Soon will be listed here.

Abstract

Decompressive craniectomy is an effective strategy to reduce intracranial hypertension after traumatic brain injury (TBI), but it is related to many postoperative complications, such as delayed intracranial hematoma and diffuse brain swelling. Our previous studies have demonstrated that controlled decompression (CDC) surgery attenuates brain injury and reduces the rate of complications after TBI. Here, we investigated the potential molecular mechanisms of CDC in experimental models. The in vitro experiments were performed in a traumatic neuronal injury (TNI) model following compression treatment in primary cultured cortical neurons. We found that compression aggravates TNI-induced neuronal injury, which was significantly attenuated by CDC for 2 h or 3 h. The results of immunocytochemistry showed that CDC reduced neuronal necroptosis and activation of RIP3 induced by TNI and compression, with no effect on RIP1 activity. These protective effects were associated with decreased levels of inflammatory cytokines and preserved intracellular Ca homeostasis. In addition, the expression of the two-pore domain K channel TREK-1 and its activity was increased by compression and prolonged by CDC. Treatment with the TREK-1 blockers, spadin or SID1900, could partially prevent the effects of CDC on intracellular Ca metabolism, necroptosis, and neuronal injury following TNI and compression. Using a traumatic intracranial hypertension model in rats, we found that CDC for 20 min or 30 min was effective in alleviating brain edema and locomotor impairment in vivo. CDC significantly inhibited neuronal necroptosis and neuroinflammation and increased TREK-1 activation, and the CDC-induced protection in vivo was attenuated by spadin and SID1900. In summary, CDC is effective in alleviating compressive neuronal injury both in vitro and in vivo, which is associated with the TREK-1-mediated attenuation of intracellular Ca overload, neuronal necroptosis, and neuroinflammation.

Citing Articles

The neuroprotection of controlled decompression after traumatic epidural intracranial hypertension through suppression of autophagy via PI3K/Akt signaling pathway.

Che Y, Wu W, Qian X, Sheng Z, Zhang W, Zheng J Heliyon. 2024; 10(1):e23753.

PMID: 38226265 PMC: 10788442. DOI: 10.1016/j.heliyon.2023.e23753.

Comparison of the effects of stepwise intracranial decompression and decompressive craniectomy in the treatment of severe traumatic brain injury: A randomized controlled trial.

Liu C, Jia G, Wu R, Yang C Medicine (Baltimore). 2023; 102(51):e36633.

PMID: 38134108 PMC: 10735114. DOI: 10.1097/MD.0000000000036633.

Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis: A Novel Therapeutic Target in Nervous System Diseases.

Tang L, Liu S, Li S, Chen Y, Xie B, Zhou J Int J Mol Sci. 2023; 24(12).

PMID: 37373274 PMC: 10299044. DOI: 10.3390/ijms241210127.

Controlled Decompression Alleviates Motor Dysfunction by Regulating Microglial Polarization via the HIF-1α Signaling Pathway in Intracranial Hypertension.

Zheng J, Zhang C, Wu Y, Zhang C, Che Y, Zhang W Mol Neurobiol. 2023; 60(10):5607-5623.

PMID: 37328678 DOI: 10.1007/s12035-023-03416-6.

Secondary hyperperfusion injury following surgical evacuation for acute isolated epidural hematoma with concurrent cerebral herniation.

Huang W, Li J, Wang W, Zhang Y, Luo F, Hu L Front Neurol. 2023; 14:1141395.

PMID: 37139069 PMC: 10149734. DOI: 10.3389/fneur.2023.1141395.

References

Bruno V, Battaglia G, Copani A, DOnofrio M, Di Iorio P, De Blasi A . Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab. 2001; 21(9):1013-33. DOI: 10.1097/00004647-200109000-00001. View

Wang Y, Wang L, Zhang M, Wang T, Bao H, Liu W . Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model. Neurochem Res. 2012; 37(9):1849-58. DOI: 10.1007/s11064-012-0791-4. View

Yarishkin O, Phuong T, Bretz C, Olsen K, Baumann J, Lakk M . TREK-1 channels regulate pressure sensitivity and calcium signaling in trabecular meshwork cells. J Gen Physiol. 2018; 150(12):1660-1675. PMC: 6279358. DOI: 10.1085/jgp.201812179. View

Wang Y, Wang C, Yang L, Cai S, Cai X, Dong J . Controlled decompression for the treatment of severe head injury: a preliminary study. Turk Neurosurg. 2014; 24(2):214-20. DOI: 10.5137/1019-5149.JTN.8135-13.1. View

Namiranian K, Brink C, Goodman J, Robertson C, Bryan Jr R . Traumatic brain injury in mice lacking the K channel, TREK-1. J Cereb Blood Flow Metab. 2010; 31(3):e1-6. PMC: 3063636. DOI: 10.1038/jcbfm.2010.223. View

Loane D, Stoica B, Faden A . Neuroprotection for traumatic brain injury. Handb Clin Neurol. 2015; 127:343-66. PMC: 4808298. DOI: 10.1016/B978-0-444-52892-6.00022-2. View

Djillani A, Mazella J, Heurteaux C, Borsotto M . Role of TREK-1 in Health and Disease, Focus on the Central Nervous System. Front Pharmacol. 2019; 10:379. PMC: 6470294. DOI: 10.3389/fphar.2019.00379. View

Bhat A, Kirmani A, Wani M . Decompressive craniectomy with multi-dural stabs - A combined (SKIMS) technique to evacuate acute subdural hematoma with underlying severe traumatic brain edema. Asian J Neurosurg. 2013; 8(1):15-20. PMC: 3667455. DOI: 10.4103/1793-5482.110275. View

Meng Y, Sandow J, Czabotar P, Murphy J . The regulation of necroptosis by post-translational modifications. Cell Death Differ. 2021; 28(3):861-883. PMC: 7937688. DOI: 10.1038/s41418-020-00722-7. View

10.

Ni H, Rui Q, Lin X, Li D, Liu H, Chen G . 2-BFI Provides Neuroprotection Against Inflammation and Necroptosis in a Rat Model of Traumatic Brain Injury. Front Neurosci. 2019; 13:674. PMC: 6606784. DOI: 10.3389/fnins.2019.00674. View

11.

Wang W, Kiyoshi C, Du Y, Taylor A, Sheehan E, Wu X . TREK-1 Null Impairs Neuronal Excitability, Synaptic Plasticity, and Cognitive Function. Mol Neurobiol. 2019; 57(3):1332-1346. PMC: 8808335. DOI: 10.1007/s12035-019-01828-x. View

12.

De Loof A . The essence of female-male physiological dimorphism: differential Ca2+-homeostasis enabled by the interplay between farnesol-like endogenous sesquiterpenoids and sex-steroids? The Calcigender paradigm. Gen Comp Endocrinol. 2014; 211:131-46. DOI: 10.1016/j.ygcen.2014.12.003. View

13.

Djillani A, Pietri M, Mazella J, Heurteaux C, Borsotto M . Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin. Pharmacol Ther. 2018; 194:185-198. DOI: 10.1016/j.pharmthera.2018.10.003. View

14.

Ingram J, Thapa R, Fisher A, Tummers B, Zhang T, Yin C . ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1. J Immunol. 2019; 203(5):1348-1355. PMC: 6702065. DOI: 10.4049/jimmunol.1900216. View

15.

Wu X, Liu Y, Chen X, Sun Q, Tang R, Wang W . Involvement of TREK-1 activity in astrocyte function and neuroprotection under simulated ischemia conditions. J Mol Neurosci. 2012; 49(3):499-506. DOI: 10.1007/s12031-012-9875-5. View

16.

Cao L, Mu W . Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications. Pharmacol Res. 2020; 163:105297. PMC: 7962892. DOI: 10.1016/j.phrs.2020.105297. View

17.

Alves O, Bullock R . "Basal durotomy" to prevent massive intra-operative traumatic brain swelling. Acta Neurochir (Wien). 2003; 145(7):583-6; discussion 586. DOI: 10.1007/s00701-003-0055-9. View

18.

Kolias A, Adams H, Timofeev I, Czosnyka M, Corteen E, Pickard J . Decompressive craniectomy following traumatic brain injury: developing the evidence base. Br J Neurosurg. 2016; 30(2):246-50. PMC: 4841020. DOI: 10.3109/02688697.2016.1159655. View

19.

Hivelin C, Beraud-Dufour S, Devader C, Abderrahmani A, Moreno S, Moha Ou Maati H . Potentiation of Calcium Influx and Insulin Secretion in Pancreatic Beta Cell by the Specific TREK-1 Blocker Spadin. J Diabetes Res. 2017; 2016:3142175. PMC: 5220496. DOI: 10.1155/2016/3142175. View

20.

Fang Y, Tian Y, Huang Q, Wan Y, Xu L, Wang W . Deficiency of TREK-1 potassium channel exacerbates blood-brain barrier damage and neuroinflammation after intracerebral hemorrhage in mice. J Neuroinflammation. 2019; 16(1):96. PMC: 6506965. DOI: 10.1186/s12974-019-1485-5. View